 | Up a level |
Journal Article
Rhodes, Joanna, Sail, Kavita, Yazdy, Maryam, Hill, Brian, Shadman, Mazyar, Tuncer, Hande H., Winter, Allison, Kennard, Kaitlin, Allan, John, Ujjani, Chaitra, Brander, Danielle, Cho, Sang Kyu, Sharmokh, Simon, Jiang, Dingfeng, Nabhan, Chadi, Barr, Paul 
ORCID: 0000-0002-9733-401X, Brown, Jennifer, Fox, Christopher, Schuh, Anna, Eyre, Toby, Lamanna, Nicole ORCID: 0000-0003-3331-9491, Wierda, William, Skarbnik, Alan, Roeker, Lindsey, Bannerji, Rajat, Evens, Andrew M., Pauff, James M., Schuster, Steven, Follows, George, Cheson, Bruce D., Eichhorst, Barbara and Mato, Anthony
(2020).
Factors impacting treatment selection in treatment-naive patients with CLL: a multicenter study.
Leuk. Lymphoma, 61.
S. 104 - 106.
ABINGDON:
TAYLOR & FRANCIS LTD.
ISSN 1029-2403
Mato, Anthony R., Yazdy, Maryam Sarraf, Hill, Brian T., Shadman, Mazyar, Tuncer, Hande, Winter, Allison M., Kennard, Kaitlin, Allan, John N., Ujjani, Chaitra S., Brander, Danielle M., Nabhan, Chadi, Barr, Paul ORCID: 0000-0002-9733-401X, Brown, Jennifer R., Fox, Christopher P., Rhodes, Joanna, Schuh, Anna, Eyre, Toby A., Lamanna, Nicole, Jain, Nitin, Wierda, William G., Skarbnik, Alan P., Roeker, Lindsey E., Bannerji, Rajat, Evens, Andrew M., Lansigan, Frederick, Samp, Jennifer C., Nielsen, Jacqueline, Pauff, James M., Kipps, Thomas J., Schuster, Stephen J., Follows, George A., Cheson, Bruce and Eichhorst, Barbara
(2018).
Treatment Patterns and Outcomes of Patients with CLL Treated with Chemoimmuno- and Novel Agent-Based Therapy: A Multicenter Study.
Blood, 132.
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020
Kipps, Thomas J., Mahler, Michelle, Fraser, Graeme, Coutre, Steven, Brown, Jennifer, Barrientos, Jacqueline, Barr, Paul ORCID: 0000-0002-9733-401X, Byrd, John C., O'Brien, Susan, Dilhuydy, Marie Sarah, Jaeger, Ulrich, Moreno, Carol, Cramer, Paula, Stilgenbauer, Stephan, Chanan-Khan, Asher, Salman, Mariya, Cheng, Mei, Londhe, Anil, Ninomoto, Joi, Howes, Angela, James, Danelle, Hallek, Michael and Hillmen, Peter
(2017).
Outcomes of ibrutinib-treated patients with chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL) with high-risk prognostic factors in an integrated analysis of 3 randomized phase 3 studies.
Leuk. Lymphoma, 58.
S. 10 - 13.
ABINGDON:
TAYLOR & FRANCIS LTD.
ISSN 1029-2403